logo
Marico Q1 Results: Revenue grows 23.3% to Rs 3,259 crore, Net profit rises 8.2% YoY

Marico Q1 Results: Revenue grows 23.3% to Rs 3,259 crore, Net profit rises 8.2% YoY

Business Upturn04-08-2025
Marico Limited reported a consolidated net profit of Rs 513 crore for the quarter ended June 30, 2025, up 8.2% from Rs 474 crore in the same quarter last year. Sequentially, profit grew nearly 49% compared to Rs 345 crore in Q4 FY25.
Revenue from operations rose to Rs 3,259 crore in Q1 FY26, marking a 23.3% year-on-year increase from Rs 2,643 crore in Q1 FY25. On a quarter-on-quarter basis, revenue was up 19.4% from Rs 2,730 crore in Q4 FY25.
Total expenses stood at Rs 2,659 crore, compared to Rs 2,075 crore in the year-ago period and Rs 2,336 crore in the preceding quarter. Profit before tax for the quarter came in at Rs 656 crore, up from Rs 605 crore in Q1 FY25.
Tax expense for the quarter was Rs 143 crore, higher than the Rs 131 crore reported in the same period last year.
Marico continues to show steady operational performance backed by higher revenue and controlled cost structures across segments.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Prostarm Info bags 150 MW/300 MWh battery storage order from KPTCL
Prostarm Info bags 150 MW/300 MWh battery storage order from KPTCL

Business Upturn

time3 hours ago

  • Business Upturn

Prostarm Info bags 150 MW/300 MWh battery storage order from KPTCL

Prostarm Info Systems Limited has been declared the L-1 bidder by Karnataka Power Transmission Corporation Limited (KPTCL) for a landmark energy storage project. The company will set up a 150 MW/300 MWh standalone Battery Energy Storage System (BESS) at the 400kV Doni Substation in Gadag District, Karnataka, operating at 220kV voltage level. The project, awarded under the Tariff Based Competitive Bidding (TBCB) mode, will be executed on a Build-Own-Operate (BOO) basis for 12 years. Prostarm Info Systems will receive a rental of Rs. 2.54 lakh per MW per month, amounting to an annual rental of Rs. 45.72 crore for the entire 150 MW/300 MWh system. Additionally, the project includes Viability Gap Funding (VGF) of Rs. 27 lakh per MWh or 30% of the capital cost for the BESS, whichever is lower. This order marks a significant milestone for Prostarm Info Systems, reinforcing its position in India's renewable energy and energy storage sector. The project is entirely domestic, and there are no related party concerns or promoter interests involved in the award. With this strategic contract, Prostarm Info Systems is poised to contribute significantly to Karnataka's energy infrastructure while advancing sustainable energy solutions. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Room to Read India Launches 7th Edition of the Nationwide India Gets Reading Campaign
Room to Read India Launches 7th Edition of the Nationwide India Gets Reading Campaign

Business Upturn

time4 hours ago

  • Business Upturn

Room to Read India Launches 7th Edition of the Nationwide India Gets Reading Campaign

By Business Wire India Published on August 20, 2025, 15:25 IST Room to Read India has launched the seventh edition of its annual flagship initiative, India Gets Reading, reaffirming its commitment to advancing early learning for children across the country. Business Wire India Room to Read India has launched the seventh edition of its annual flagship initiative, India Gets Reading, reaffirming its commitment to advancing early learning for children across the country. With the potential to reach over 40 lakh children, th is year's theme, 'My Book, My Story', celeb rates the magic of seeing oneself in stories. Across Delhi, Himachal Pradesh, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Telangana, Uttarakhand, and Uttar Pradesh, it will spark on-ground activations that bring reading closer to every child's heart. Poornima Garg, Country Director at Room to Read India , emphasized the far-reaching positive influence of early education: 'When children see their own lives, languages, and stories reflected in the books they read, and when parents, teachers, and caregivers join them in those reading spaces, we nurture not just readers, but confident dreamers. This year, our focus is on creating opportunities where children can comprehend stories rooted in their local context, while feeling the dignity, inclusion, and agency to shape their own future. In alignment with the vision of NEP 2020 and the NIPUN Bharat Mission, which prioritize foundational literacy and numeracy for every child, our campaign will continue working with state governments and partners to cultivate joyful reading spaces across the country.' Designed to extend learning beyond the classroom, the campaign emphasizes safe, inclusive, and empowering spaces where children can read and learn in ways that reflect their realities. Key highlights of the 2025 edition include a ten-day Pledge Reading Time activity, a Read-a-thon, and mobile libraries in various shapes and forms that bring diverse children's literature directly into communities. Anchored in the belief that every child deserves to read with dignity, India Gets Reading is a unifying call to action, urging communities, educators, and policymakers to amplify every child's voice and build participatory, inclusive learning environments. Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash Business Wire India, established in 2002, India's premier media distribution company ensures guaranteed media coverage through its network of 30+ cities and top news agencies.

Lupin launches Bosentan Tablets for Oral Suspension in US with 180-day exclusivity
Lupin launches Bosentan Tablets for Oral Suspension in US with 180-day exclusivity

Business Upturn

time10 hours ago

  • Business Upturn

Lupin launches Bosentan Tablets for Oral Suspension in US with 180-day exclusivity

By Aditya Bhagchandani Published on August 20, 2025, 10:16 IST Shares of Lupin Ltd. will be in focus on Wednesday, August 20, after the company announced the launch of Bosentan Tablets for Oral Suspension, 32 mg, in the United States. The launch, made in partnership with NATCO Pharma, comes with the advantage of 180-day first-to-file generic exclusivity, a significant opportunity in the niche space of pulmonary arterial hypertension (PAH) treatment. The government filing confirmed that Lupin's alliance partner NATCO Pharma received U.S. FDA approval for its Abbreviated New Drug Application (ANDA). Bosentan is indicated for the treatment of PAH in pediatric patients aged three years and above with idiopathic or congenital PAH, aiming to improve pulmonary vascular resistance and exercise ability. The drug is bioequivalent to Actelion Pharmaceuticals' Tracleer® Tablets for Oral Suspension, which had estimated annual U.S. sales of around USD 10 million as of June 2025. Lupin, a major player in generics and specialty formulations, continues to strengthen its U.S. portfolio with this launch. The company has a strong footprint across therapy areas, including respiratory, cardiovascular, anti-diabetic, and women's health, and operates 15 manufacturing sites and seven research centers globally. With the exclusivity window, Lupin and NATCO are positioned to capture market share in the PAH treatment segment before competition intensifies. Disclaimer: This article is for informational purposes only and should not be considered investment advice. Please consult a financial advisor before making any investment decisions. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store